Sunshine A, Slafta J, Gruber C
J Clin Pharmacol. 1978 Nov-Dec;18(11-12):556-63. doi: 10.1002/j.1552-4604.1978.tb01585.x.
Groups of 27 inpatients with moderate or severe postoperative, fracture, or somatic pain were given single oral doses of propoxyphene napsylate (P), fenoprofen calcium (F), combinations of P and F, aspirin, or placebo. The increasing rank order for effectiveness, with doses in milligrams, was placebo, P50, aspirin 650, F600, F50, P50 + F50, F200, P50 + F600, P50 + F200, P200 + F50, P200, P200 + F200, and P200 + F600. The overall analgesic response to propoxyphene in this dose range (50 to 200 mg) increased linearly with increasing doses. The fenoprofen response also increased in proportion to the dose up to 200 mg; the overall response to 600 mg was not significantly different from that to 200 mg. Propoxyphene napsylate and fenoprofen calcium had additive analgesic effects. There were no drug-related adverse reports.
将27名患有中度或重度术后疼痛、骨折疼痛或躯体疼痛的住院患者分为几组,分别单次口服萘磺酸丙氧芬(P)、萘普生钙(F)、P与F的组合、阿司匹林或安慰剂。按毫克剂量排列,有效性递增顺序为安慰剂、50毫克P、650毫克阿司匹林、600毫克F、50毫克F、50毫克P + 50毫克F、200毫克F、50毫克P + 600毫克F、50毫克P + 200毫克F、200毫克P + 50毫克F、200毫克P、200毫克P + 200毫克F、200毫克P + 600毫克F。在此剂量范围(50至200毫克)内,萘磺酸丙氧芬的总体镇痛反应随剂量增加呈线性增加。萘普生钙的反应在剂量高达200毫克时也与剂量成比例增加;600毫克时的总体反应与200毫克时无显著差异。萘磺酸丙氧芬和萘普生钙具有相加的镇痛作用。未出现与药物相关的不良报告。